NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elm Biosciences

Elm Biosciences

Private
New York City, New YorkConsumer & Commercehttps://elmbiosciences.com/

Last Round

Seed

Aug 20, 2025

Total Funding Raised

$3.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elm Biosciences is a personal products company that develops clinical skincare products designed to address the signs of aging.

Sector

Consumer & Commerce

Verticals

D2C Brands, Fashion & Beauty, Biotechnology

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

clinical skincareanti-aging skincaredermatologist-developedcosmeceuticalsdual-pathway skincareoral skin supplementantioxidant serumingestible beautyderm-backed brandskin longevityD2C brandcelebrity beauty brandskincare subscriptionB2B2C

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elm Biosciences Comparables

Compare Elm Biosciences with similar companies based on industry and business-model similarity.

Elm Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Elm Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 20, 2025

Key People

Founding team and executive leadership

Dhaval Bhanusali

Chief Medical Officer Co-Founder

Founding Team

Natalie J Sperling

Founding CEO

Founding Team

Elm Biosciences Investors

Notable investors and investment history

Elm Biosciences investors
InvestorRounds
Red Sea VenturesSeed
Springdale VenturesSeed
Habitat PartnersSeed
Lerer HippeauSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Grew 100% QoQ from 3 to 6 employees.

  • Apr 25, 2026

    Monthly visitors increased 130% MoM, reaching 268K.

Elm Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elm Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elm Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range7
Year Founded2025
Last FundingAug 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.